Discover 290 paid clinical trials in Cape Coral, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 290
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
for
Alzheimer's Disease
Location: Bonita Springs FL, Bradenton FL, Tampa FL, Miami FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011745
Phase3, Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
for
Psychotic Disorders, Alzheimer Disease
Location: Bonita Springs FL, Sarasota FL, Brandon FL, Tampa FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06540833
Phase2, Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for
Psychosis Associated With Alzheimer's Disease
Location: Bonita Springs FL, Tampa FL, Miami FL, Hialeah FL,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT05980949
Phase3, Recruiting
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Location: Bonita Springs FL, Port Charlotte FL, Tampa FL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT07105111
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
for
Wet Age Related Macular Degeneration
Location: Bonita Springs FL, Tulsa OK, Erie PA
Sponsor: NexThera Co., Ltd.
Sex: All
Age: 50+
Code: NCT07811726
Phase2, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Bonita Springs FL, St. Petersburg FL, Winter Haven FL,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization